ROBERT PETIT

CIK 1576077 · See Remarks · last filed 2026-02-13

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$340.0K

Companies

4

Total Filings

63

Lifetime Open-Market Net

-$208.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
OSTX	See Remarks	200,000	$1.70	$340.0K	$0	2	2026-02-13
Ayala Pharmaceuticals, Inc. (ADXS) Delisted	Chief Scientific Officer	231,206	$0.60	$139.6K	-$7.1K	2	2018-11-07
Ayala Pharmaceuticals, Inc. (ADXSW) Delisted	Chief Scientific Officer	243,660	—	—	-$99.6K	25	2018-08-01
Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted	Chief Scientific Officer	123,378	—	—	-$102.0K	34	2016-10-04

Recent Filings · Page 7 of 7

63 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2014-01-10	Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted	Mixed	+91,676	-$33.5K	EDGAR
2014-01-09	Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted	Grant (A)	+8,847	$0	EDGAR
2013-10-28	Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted	Buy (P)	+12,800	$51.2K	EDGAR

Showing 61–63 of 63

Prev Page 7 of 7

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.